News Releases

April 30, 2013

RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders
VANCOUVER, BC – June 11, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB:REPCF) presented significant new data from its Phase I/IIa... Read full article

April 18, 2013

RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX:RP) is pleased to announce that it... Read full article

April 10, 2013

RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF and CNSX: RP) is pleased to announce... Read full article

February 19, 2013

RepliCel to Present at the 11th Annual BioPartnering North America Conference
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013 VANCOUVER, BC – February 19th 2013 – RepliCel Life Sciences Inc (the “Company” or “RepliCel”) (OTCBB:... Read full article

February 8, 2013

RepliCel Announces Re-Pricing of Warrants
VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX:RP) announces that it has received Exchange... Read full article

February 4, 2013

RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process
Phase II Dose Ranging Trial Planned for 2013 VANCOUVER, BC – February 4, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:... Read full article

November 7, 2012

RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Pro
Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013 VANCOUVER, BC – November 7, 2012 – RepliCel Life... Read full article

September 27, 2012

RepliCel’s Common Shares Listed on CNSX
VANCOUVER, BC – October 1, 2012  – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:REPCF) today announces that its common shares have been... Read full article

September 26, 2012

RepliCel’s Chief Medical Officer to Present at 21st European Academy of Dermatology & Venereology Congress
VANCOUVER, BC – September, 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:REPCF) today announces that Dr. Rolf Hoffmann, RepliCel’s Chief Medical Officer, will... Read full article

September 10, 2012

RepliCel to Present at Rodman and Renshaw Global Investment Conference
VANCOUVER, BC – September 10, 2012 – RepliCel Life Sciences Inc.’s (the “Company” or “RepliCel”) (OTCBB:REPCF) today announces that David Hall, CEO and President, will be presenting... Read full article